Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Powles

Showing results (171-180 of 275) with videos related to

Pageof 28
Sort By:
Carcinogenesis|July 1, 1995
32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifenE A Martin, K J Rich, I N White, et al.
Breast Cancer Research and Treatment|April 16, 1998
Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with responseA Makris, T J Powles, D C Allred, et al.
The Journal of Laryngology and Otology|April 8, 2004
Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virusT Powles, J Powles, M Nelson, et al.
Breast Cancer Research and Treatment|December 25, 2003
Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancerL Assersohn, J Salter, T J Powles, et al.
Lancet (London, England)|March 15, 1980
Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancerT J Powles, R C Coombes, I E Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patientsM Dowsett, A Mehta, N King, et al.
Breast Cancer Research and Treatment|January 1, 1992
Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatmentP E Lønning, M Dowsett, A Jones, et al.
Cancer|August 15, 1983
Assessment of response of bone metastases to systemic treatment in patients with breast cancerR C Coombes, P Dady, C Parsons, et al.
Cancer Research|September 1, 1986
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II reportP E Goss, T J Powles, M Dowsett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention studyJ Chang, T J Powles, S E Ashley, et al.
Pageof 28

Showing results (171-180 of 275) with videos related to

Sort By:
Pageof 28
Carcinogenesis|July 1, 1995
32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifenE A Martin, K J Rich, I N White, et al.
Breast Cancer Research and Treatment|April 16, 1998
Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with responseA Makris, T J Powles, D C Allred, et al.
The Journal of Laryngology and Otology|April 8, 2004
Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virusT Powles, J Powles, M Nelson, et al.
Breast Cancer Research and Treatment|December 25, 2003
Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancerL Assersohn, J Salter, T J Powles, et al.
Lancet (London, England)|March 15, 1980
Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancerT J Powles, R C Coombes, I E Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patientsM Dowsett, A Mehta, N King, et al.
Breast Cancer Research and Treatment|January 1, 1992
Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatmentP E Lønning, M Dowsett, A Jones, et al.
Cancer|August 15, 1983
Assessment of response of bone metastases to systemic treatment in patients with breast cancerR C Coombes, P Dady, C Parsons, et al.
Cancer Research|September 1, 1986
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II reportP E Goss, T J Powles, M Dowsett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention studyJ Chang, T J Powles, S E Ashley, et al.
Pageof 28